Literature DB >> 6418063

Antibiotic prophylaxis against streptomycin-resistant and -susceptible Streptococcus faecalis endocarditis in rabbits.

P A Guze, G M Kalmanson, L R Freedman, K Ishida, L B Guze.   

Abstract

This report describes the capacities of ampicillin, vancomycin, streptomycin, gentamicin, and combinations thereof to prevent endocarditis in rabbits challenged with either streptomycin-resistant (three strains) or streptomycin-susceptible (one strain) Streptococcus faecalis. Vancomycin (15 mg/kg) alone was effective in preventing infection with three of four strains, including two which were streptomycin resistant. Vancomycin (30 mg/kg) alone was effective against the other streptomycin-resistant strain. The vancomycin-gentamicin combination was the only therapeutic regimen to demonstrate complete prophylaxis for all strains regardless of streptomycin susceptibility. The ampicillin-gentamicin combination was variably effective despite in vitro synergism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418063      PMCID: PMC185365          DOI: 10.1128/AAC.24.4.514

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.

Authors:  S A Calderwood; C Wennersten; R C Moellering; L J Kunz; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

2.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

3.  Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis.

Authors:  J Y Matsumoto; W R Wilson; A J Wright; J E Geraci; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

4.  Antibiotic synergism of enterococci. Relation to inhibitory concentrations.

Authors:  H D Standiford; J B De Maine; W M Kirby
Journal:  Arch Intern Med       Date:  1970-08

5.  Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism.

Authors:  D J Krogstad; T R Korfhagen; R C Moellering; C Wennersten; M N Swartz
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

6.  Antimicrobial therapy of experimental enterococcal endocarditis.

Authors:  E W Hook; R B Roberts; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

7.  Recognition of group D streptococcal species of human origin by biochemical and physiological tests.

Authors:  R R Facklam
Journal:  Appl Microbiol       Date:  1972-06

8.  Chemotherapy of experimental streptococcal endocarditis. V. Effect of duration of infection and retained intracardiac catheter on response to treatment.

Authors:  L L Pelletier; R G Petersdorf; K Nielson
Journal:  J Lab Clin Med       Date:  1976-04

9.  Pyelonephritis. I. Observations on the course of chronic non-obstructed enterococcal infection in the kidnev of the rat.

Authors:  L B GUZE; B H GOLDNER; G M KALMANSON
Journal:  Yale J Biol Med       Date:  1961-04

10.  Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart.

Authors:  P K Garrison; L R Freedman
Journal:  Yale J Biol Med       Date:  1970-06
View more
  1 in total

Review 1.  The bacteremia of dental origin and its implications in the appearance of bacterial endocarditis.

Authors:  María-Rocío Mang-de la Rosa; Lizett Castellanos-Cosano; María-Jesús Romero-Perez; Antonio Cutando
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.